Vis enkel innførsel

dc.contributor.authorNieder, Carsten
dc.contributor.authorGrant, David McKenzie
dc.date.accessioned2023-09-04T09:13:46Z
dc.date.available2023-09-04T09:13:46Z
dc.date.issued2023-11-08
dc.description.abstractRadiation to the carotid arteries, e.g. in the context of head and neck cancer treatment, is one of several risk factors for artery stenosis. In principle, this fact may also have implications for stereotactic cervical spine radiotherapy, because long-term survival can be achieved in patients with oligometastatic disease and favorable prognostic features. Here, we suggest that radiation dose distributions with reduced dose to the carotid artery are achievable when planning stereotactic cervical spine radiotherapy. Patients with high likelihood of long-term survival may benefit from such vessel-sparing approaches.en_US
dc.identifier.citationNieder, Grant. Considerations regarding carotid artery dose in radiotherapy of the cervical spine. Clinical and Translational Radiation Oncology. 2023;38:77-80en_US
dc.identifier.cristinIDFRIDAID 2131988
dc.identifier.doi10.1016/j.ctro.2022.11.002
dc.identifier.issn2405-6308
dc.identifier.urihttps://hdl.handle.net/10037/30651
dc.language.isoengen_US
dc.publisherElsevieren_US
dc.relation.journalClinical and Translational Radiation Oncology
dc.rights.accessRightsopenAccessen_US
dc.rights.holderCopyright 2023 The Author(s)en_US
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0en_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)en_US
dc.titleConsiderations regarding carotid artery dose in radiotherapy of the cervical spineen_US
dc.type.versionpublishedVersionen_US
dc.typeJournal articleen_US
dc.typeTidsskriftartikkelen_US
dc.typePeer revieweden_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
Med mindre det står noe annet, er denne innførselens lisens beskrevet som Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)